Oligomeric α-synuclein is increased in basal tears of Parkinson's patients

Biomark Med. 2019 Aug;13(11):941-952. doi: 10.2217/bmm-2019-0167. Epub 2019 Jul 2.

Abstract

Aim: Secretion of proteins into basal tears of Parkinson's disease (PD) patients may be altered by changes in nerve function. Materials & methods: Oligomeric α-SynOligo and total α-SynTotal, CCL-2, DJ-1, LF and MMP-9 were measured in basal tears from 93 PD patients and 82 age- and sex-equivalent healthy controls. Results: α-SynTotal was decreased (p = 0.0043), whereas α-SynOligo (p < 0.0001) and the ratio of α-SynOligo/α-SynTotal (p < 0.0001) were increased in basal tears from PD patients compared with healthy controls. Area under receiver-operating curves of α-SynOligo and α-SynOligo/α-SynTotal contents were 0.70 (95% confidence limits: 0.621-0.774) and 0.72 (95% confidence limits: 0.642-0.792). Conclusion: PD patient basal tears may contain biomarkers that can be assayed noninvasively and inexpensively.

Keywords: Parkinson’s disease; biofluid; biomarker; oligomeric α-synuclein; tears; α-synuclein.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / analysis*
  • Biomarkers / metabolism
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Parkinson Disease / metabolism*
  • Tears / chemistry*
  • Tears / metabolism
  • alpha-Synuclein / analysis
  • alpha-Synuclein / metabolism*

Substances

  • Biomarkers
  • alpha-Synuclein